UK projects growth in drug spending through 2014

04/15/2013 | PharmaTimes (U.K.)

Annual spending in the U.K. will increase by 0.5% to 1.8% on branded drugs and 10% to 11% on generics through 2015, according to the Office of Health Economics. Analysts used a new "bottom-up" method to base the forecast on input from industry executives regarding new branded products as well as generic and biosimilar drugs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ